People are more likely to report short-term memory loss after starting cholesterol-lowering drugs known as statins, but the finding probably has nothing to do with the medications, a new study suggests. “It’s a completely false alarm that doesn’t look like it’s real and shouldn’t enter into the equation of whether or not someone should take […]

Amgen Inc’s experimental drug Repatha lowered cholesterol in clinical trials and did not cause a marked disparity in deaths or serious adverse events but showed potential safety issues that should be explored, according to a preliminary review by the U.S. Food and Drug Administration. The review was published on Monday on the FDA’s website before […]

This coming week is likely to be a serious one in the fight against cholesterol. This covers a new class of drugs in the PCSK9 classification, and FDA panels are evaluating more than just one drug candidate. A U.S. Food and Drug Administration (FDA) advisory panel is expected to meet on June 9 to consider […]